Abiopharma

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease

Aterian, Inc. Announces Mailing of Proxy Materials for Special Meeting of Stockholders

Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption

Zeta Global Brings Athena by Zeta™ to Agencies, Putting Agentic AI at the Center of Every Marketing Decision

Enphase Energy Begins Shipments of GaN-Based 548 VA IQ9S Commercial Microinverters in the United States

Allegro MicroSystems Appoints Brian White to its Board of Directors

Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026

Premier Air Charter Discusses FAA Approval, Growth Strategy, and Market Trends in Follow-Up Interview

Hollister Teams Up with Target for Its First-Ever Home & Dorm Collaboration

Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million